Pachaiyappan Viswanathan

Overview

Explore the profile of Pachaiyappan Viswanathan including associated specialties, affiliations and a list of published articles.

Snapshot

Articles 7

Citations 258

Followers 0

Related Specialties

Cell Biology

Pharmacology

Science

Top 10 Co-Authors

Pawan Kumar Gupta

Anita Dhar

Charan Thej

Raviraja N Seetharam

K Udaykumar

Anoop Chullikana

Subhendu S Mahapatra

Mathiyazhagan Rengasamy

Prasanth Kulapurathu Vellotare

Suresh Kannan

Published In

Stem Cells Transl Med

J Stem Cells

Sci Rep

Arthritis Res Ther

Stem Cell Rev Rep

Affiliations

Soon will be listed here.

Recent Articles

Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease

Gupta P, Shivashankar P, Rajkumar M, Mahapatra S, Desai S, Dhar A, et al.

Stem Cell Res Ther . 2023 Apr; 14(1):60. PMID: 37005673

Background: Peripheral arterial disease (PAD) of lower extremities comprises a clinical spectrum that extends from asymptomatic patients to critical limb ischemia (CLI) patients. 10% to 40% of the patients are...

Characteristics of Pooled Wharton's Jelly Mesenchymal Stromal Cells (WJ-MSCs) and their Potential Role in Rheumatoid Arthritis Treatment

Kannan S, Viswanathan P, Gupta P, Kolkundkar U

Stem Cell Rev Rep . 2022 Feb; 18(5):1851-1864. PMID: 35113368

Introduction: Mesenchymal stromal cells (MSC) from Wharton's jelly of umbilical cord is primitive and serve as an inexhaustible source of stem cells with greater potential in clinics. The existence of...

Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease

Gupta P, Dutta S, Kala S, Nekkanti M, Desai S, Mahapatra S, et al.

Stem Cells Transl Med . 2021 Sep; 10(12):1602-1613. PMID: 34519179

Buerger's disease or thromboangiitis obliterans is a type of obstructive vascular diseases categorized as vasculitis and usually present in 95% of young smoker men. The main pathogenetic mechanism is interplay...

Expansion and characterization of bone marrow derived human mesenchymal stromal cells in serum-free conditions

Bhat S, Viswanathan P, Chandanala S, Prasanna S, Seetharam R

Sci Rep . 2021 Feb; 11(1):3403. PMID: 33564114

Bone marrow-derived mesenchymal stromal cells (BM-MSCs) are gaining increasing importance in the field of regenerative medicine. Although therapeutic value of MSCs is now being established through many clinical trials, issues...

Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy

Gupta P, Krishna M, Chullikana A, Desai S, Murugesan R, Dutta S, et al.

Stem Cells Transl Med . 2017 Mar; 6(3):689-699. PMID: 28297569

Critical limb ischemia (CLI) due to Buerger's disease is a major unmet medical need with a high incidence of morbidity. This phase II, prospective, nonrandomized, open-label, multicentric, dose-ranging study was...

Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint

Gupta P, Chullikana A, Rengasamy M, Shetty N, Pandey V, Agarwal V, et al.

Arthritis Res Ther . 2016 Dec; 18(1):301. PMID: 27993154

Background: Osteoarthritis (OA) is a common and debilitating chronic degenerative disease of the joints. Currently, cell-based therapy is being explored to address the repair of damaged articular cartilage in the...

Effect of bFGF on HLA-DR expression of human bone marrow-derived mesenchymal stem cells

Dighe P, Viswanathan P, Mruthunjaya A, Seetharam R

J Stem Cells . 2014 Jan; 8(1):43-57. PMID: 24459812

There has been a steady rise in the therapeutic applications of bone marrow mesenchymal stem cells (BM-MSCs) because of their unique properties of multilineage differentiation and immune modulation as well...